{"data":{"id":"us-sd/sdcl-34-20b-20","jurisdiction":"us-sd","citation":"SDCL § 34-20B-20","heading":"Depressants specifically included in Schedule III.","body":"Any material, compound, mixture, or preparation is included in Schedule III that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:\n(1) Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules;\n(2) Chloral betaine;\n(3) Chloral hydrate;\n(4) Chlorhexadol;\n(5) Lysergic acid;\n(6) Lysergic acid amide;\n(7) Methyprylon;\n(8) Sulfondiethylmethane;\n(9) Sulfonethylmethane;\n(10) Sulfonmethane;\n(11) Amobarbital, pentobarbital, and secobarbital in suppository dosage form;\n(12) Gamma hydroxy butyrate;\n(13) Dronabinol in sesame oil and encapsulated in a gelatin capsule in a drug product approved for marketing by the United States Food and Drug Administration;\n(14) Buprenorphine;\n(15) Embutramide;\n(16) Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers.","path":["TITLE 34. PUBLIC HEALTH AND SAFETY","CHAPTER 34-20B. DRUGS AND SUBSTANCES CONTROL"],"source_url":"https://sdlegislature.gov/Statutes/34-20B-20","current_through":"2026-08-31","vintage":"","retrieved_at":"2026-09-03T15:18:57Z","sha256":"0411271f657749a7c5233695e9045b9c9f219d22b8d791f3d1fa5b63131b5057","source_id":"us-sd","stale":true,"prev":"us-sd/sdcl-34-20b-19.1","next":"us-sd/sdcl-34-20b-20.1"},"notice":"GroundRules: Original legal text. Not legal advice."}